Printer Friendly

DIAGNOSTEK ANNOUNCES MANAGEMENT REORGANIZATION

 ALBUQUERQUE, N.M., Jan. 7 /PRNewswire/ -- Diagnostek, Inc. (NYSE: DXK) today announced a management reorganization which reflects the Company's rapid growth and maturation as a leading provider of comprehensive pharmacy services and drug benefits.
 Nunzio P. DeSantis, R.Ph., the Company's Chairman and Chief Executive Officer, said, "The reorganization substantially eliminates multiple duplicate management functions within the Company's three primary operating subsidiaries, Health Care Services (HCS), HPI Health Care Services (HPI) and Perform Cost Management Services (Perform), and allows the Company as a whole to offer custom, specialized services, de-emphasizing the separate services historically offered individually by such subsidiaries.
 "In addition, the reorganization allows the Company to quickly consolidate and incorporate the businesses and operating functions of our two recent acquisitions, Perform and Chronitech Health Services (Chronitech). As important, it better utilizes and recognizes the proven talents of senior management," said DeSantis.
 DeSantis announced that Duke Rodriguez, formerly Executive Vice President -- Chief Operating Officer, had been appointed President and Chief Operating Officer. Additionally, DeSantis made the following appointments:
 Warren Schelling, R.Ph., President of HPI, was appointed Executive Vice President and Pharmacy Services Officer.
 Dr. Arthur Solomon, R.Ph., President of HCS, was appointed Executive Vice President and Managed Care Officer.
 Robert Field, President of Perform, was appointed Executive Vice President and Sales Officer.
 Paul Morabito, President of Chronitech, was appointed Senior Vice President and Corporate Development Officer.
 David Jones, Director of Marketing, was appointed Senior Vice President and Marketing Officer.
 Debra Stroup, Executive Vice President of Perform, was appointed Senior Vice President and Client/Customer Service Officer.
 Dr. Terry Killilea, R.Ph., Vice President, Clinical Pharmacy of HCS, was appointed Senior Vice President and Clinical Services Officer.
 William Barron, Executive Vice President and Chief Financial Officer, Courtlandt Miller, Executive Vice President and Legal Officer, and Vincent Villanueva, Vice President of Corporate and Public Affairs, will continue in their present roles.
 Diagnostek manages prescription drug benefits for Fortune 500 corporations, Blue Cross and Blue Shield organizations, health maintenance organizations, preferred provider organizations, organized labor and insurance carriers. In addition, Diagnostek provides pharmacy management services to more than 200 acute-care hospitals, related inpatient facilities and health maintenance organizations nationwide.
 -0- 1/10/94
 /CONTACT: Bill Barron of Diagnostek, 505-345-8080; or Fredric Spar of Kekst and Co., 212-593-2655/
 (DXK) CO: Diagnostek, Inc. ST: New Mexico IN: HEA SU: PER


LG -- NY028 -- 0456 01/10/94 09:35 EST
COPYRIGHT 1994 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1994 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Jan 10, 1994
Words:396
Previous Article:KEPTEL, INC. REPORTS STRONG FIRST QUARTER RESULTS
Next Article:CIC ANNOUNCES PenDOS-LITE AND PenDOS-HANDWRITER RECOGNIZER FOR THE HANDHELD PDA AND PEN COMPUTERS
Topics:

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters